Pharmacokinetics of d(+)-usnic acid in rabbits after intravenous administration

  • D. Venkataramana
  • D. R. Krishna


The pharmacokinetics of usnic acid, a lichen antitubercular, antitumor and enzyme inhibiting agent, was studied in normal male rabbits after administration of 5 mg/kg dose by intravenous route. Plasma samples were collected up to 48 h. The plasma usnic acid levels showed a triexponential decay with a terminal half life of 10.69 h. The mean volume of distribution of the central compartment was 43.93 ml/kg. The pharmacokinetic parameters obtained from a three-compartment body model and a noncompartment body model gave close values. The mean steady-state volume of distribution was 167.17 and 163.29 ml/kg, systemic clearance was 12.17 and 12.25 ml/h/kg and AUC was 428.51 and 426.69 μ following three-compartmental and noncompartmental analyses respectively.


d(+)-Usnic acid rabbits pharmacokinetics 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Glasby J.S. (1976): In: Encyclopedia of Antibiotics, London: John Wiley & Sons, pp. 352.Google Scholar
  2. 2.
    Stoll A., Brack A., Reng J. (1947): The antibiotic effect of usnic acid on mycobacteria and microorganisms. Experientia, 3, 115–117.CrossRefPubMedGoogle Scholar
  3. 3.
    Helki M., Sasaki T. (1950): Chemotherapy in experimental diphtheria infection. Jap. Med. J., 3, 49–58.Google Scholar
  4. 4.
    Helki M., Nishikawa T., Miki Fugli (1952): Experimental studies in the treatment of tetanus and a case of tetanus treated with usnic acid. Jap. J. Med. Sci., 5, 89–100.Google Scholar
  5. 5.
    Zatulovsky B.G. (1954): The effect of usnic acid onM. tuberculosis and other experimental infections. Mikrobiol. Zhur. Akad. Nauk Ukr SSR, 16 (2), 54–61.Google Scholar
  6. 6.
    Risto P., Jorma, P., Sipi Siintola, Heilala P. (1950): The influence of 1-usnic acid on experimental guinea pig tuberculosis. Ann. Med. Exp. Biol. Fenniae, 28, 191–208.Google Scholar
  7. 7.
    Marshak A., Kuschner M. (1950): Acation of streptomycin and usnic acid on the development of tuberculosis in guines pigs. US Publ. Health Reports, 65, 131–144.Google Scholar
  8. 8.
    Jorma P., Risto P. (1954): 1-Usnic acid and observations on its effect on human tuberculosis. Ann. Med. Exp. Biol. Fenniae, 32 (8), 22.Google Scholar
  9. 9.
    Sipi Siintola, Heilala P., Jorma P., Risto, P. (1948): Usnic acid and its possible use in medicine. Soumen Kemisti, 21A, 179–183.Google Scholar
  10. 10.
    Kupchan S.M., Kopperman H.L. (1975): Tumor inhibitor isolated from lichens. Experientia, 31 (6), 625.CrossRefPubMedGoogle Scholar
  11. 11.
    Takai M., Uehara Y., Beisler JA. (1979): Usnic acid derivatives as potential antineoplastic agents. J. Med. Chem., 22 (11), 1380–1384.CrossRefPubMedGoogle Scholar
  12. 12.
    Vincent C., Cifuentes B., Garcia, F. (1980): 1-usneate-urease interactions: Binding sites for ligand. Z. Naturforsch., 35C, 1098–1100.Google Scholar
  13. 13.
    Venkataramana D., Krishna D.R. (1991): High performance liquid chromatographic determination of usnic acid in plasma. J. Chromatogr., Submitted.Google Scholar
  14. 14.
    Yamaoka K., Tanigawara Y., Nakagawa T., Uno T. (1981): A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharmacobiodyn., 4, 879–885.PubMedGoogle Scholar
  15. 15.
    Krishna D.R. (1990): RAMKIN: A computer program for model independent pharmacokinetic analysis. Ind. J. Pharm. Sci., Submitted.Google Scholar
  16. 16.
    Krishna D.R. (1988): Unpublished work.Google Scholar

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • D. Venkataramana
    • 1
  • D. R. Krishna
    • 1
  1. 1.University College of Pharmaceutical SciencesKakatiya UniversityWarangalIndia

Personalised recommendations